Ketamine and persistent anxiety.

"Anxiety" in everyday conversation covers a wide range of clinical experiences — generalized anxiety disorder (GAD), social anxiety, panic disorder, OCD-spectrum symptoms, and PTSD-related hyperarousal among them. Evidence-based first-line care usually involves psychotherapy (particularly cognitive behavioral therapy), and, when appropriate, medications such as SSRIs. These treatments help many people; they do not help everyone.

Ketamine has drawn interest as an option for patients whose anxiety has not adequately improved with first-line treatments, particularly when co-occurring with depression. It is not a first-line treatment for anxiety, and it is not a replacement for psychotherapy.

Rapid but time-limited symptom relief

Several studies have observed rapid, short-term reductions in anxiety symptoms following ketamine sessions, sometimes within hours. Effects from a single dose typically fade within days to a couple of weeks, which is why repeat protocols and integration between sessions matter.

Better with therapy than without

For anxiety specifically, evidence suggests that pairing ketamine sessions with psychotherapy or structured integration tends to produce more durable results than medication alone. Ketamine may help create a window of neuroplasticity; the work of shifting anxious patterns still happens through practice.

PTSD-related symptoms

Research on ketamine for PTSD-related symptoms is active. Some studies have observed reductions in intrusive thoughts, hyperarousal, and avoidance following supervised ketamine protocols paired with trauma-focused therapy. Long-term outcomes and optimal protocols continue to be studied.

Ketamine is not an anxiolytic in the way a benzodiazepine is. It is not intended to be used situationally for anxiety spikes, and it is not intended to replace psychotherapy or existing psychiatric medications. Any changes to other prescribed medications should happen under the supervision of your prescribing provider.

Ketamine therapy for anxiety is generally considered for adults whose symptoms have not adequately responded to standard care. Considerations that typically weigh against candidacy include uncontrolled cardiovascular disease, active psychosis or mania, certain substance use disorders, and specific medication interactions.

For patients with anxiety specifically, some experience an initial paradoxical spike in anxiety around sessions. A supervised, low-dose oral protocol with attentive integration — rather than a high-dose, high-intensity approach — is often better tolerated for anxious patients. Your provider can discuss what may work best for your situation.

Some patients notice reductions in reactivity or a sense of "distance" from anxious loops early in the program. Others take longer. A minority do not experience adequate improvement, and the clinical goal is an honest assessment of response — not persistence with a plan that is not helping.

Because anxiety is a learned pattern as much as a chemical state, integration work — journaling, exposure practices, sleep and movement, ongoing therapy — plays a central role in outcomes.

Ketamine therapy is one option among several for persistent anxiety, particularly when first-line treatments have not delivered adequate relief. Whether it is right for you is a clinical determination that requires a comprehensive medical evaluation. A free discovery call is a low-pressure first step.